RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
en
UCB SA WEBP

UCB Euronext brussels 

UCB SA (UCBxbru) is a Belgian multinational biopharmaceutical company headquartered in Brussels. The company focuses on the research, development, and commercialization of medicines for severe diseases in neurology and immunology. Key products include Cimzia (for inflammatory conditions), Vimpat and Briviact (for epilepsy), and Bimzelx (for psoriasis). UCB is a major constituent of the BEL 20 index on Euronext Brussels. The company is one of Europe's leading biopharma firms and a significant contributor to advancements in neurological and immunological therapies worldwide.

 UNC symbol info
 
 


 
Top stories by TradingView
 Technical analysis for UNC
 
UNC chart

Start trading
UCB now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)